Reference : MiRNA-29: A microRNA family with tumor-suppressing and immune-modulating properties
Scientific journals : Article
Life sciences : Biochemistry, biophysics & molecular biology
http://hdl.handle.net/10993/20275
MiRNA-29: A microRNA family with tumor-suppressing and immune-modulating properties
English
Schmitt, Martina mailto []
Margue, Christiane mailto [University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit >]
Behrmann, Iris mailto [University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit >]
Kreis, Stephanie mailto [University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit >]
2012
Current Molecular Medicine
Bentham Science Publishers Ltd.
13
4
572-585
Yes (verified by ORBilu)
International
1566-5240
[en] Biomarker; Immune response; MiR-29 family; Oncogenic; Therapeutic target; Tumor suppressor
[en] MicroRNAs (miRNAs) are ubiquitously expressed small, non-coding RNAs that negatively regulate gene expression at a post-transcriptional level. So far, over 1000 miRNAs have been identified in human cells and their diverse functions in normal cell homeostasis and many different diseases have been thoroughly investigated during the past decade. MiR-29, one of the most interesting miRNA families in humans to date, consists of three mature members miR-29a, miR-29b and miR-29c, which are encoded in two genetic clusters. Members of this family have been shown to be silenced or down-regulated in many different types of cancer and have subsequently been attributed predominantly tumor-suppressing properties, albeit exceptions have been described where miR-29s have tumor-promoting functions. MiR-29 targets expression of diverse proteins like collagens, transcription factors, methyltransferases and others, which may partake in abnormal migration, invasion or proliferation of cells and may favor development of cancer. Furthermore, members of the miR-29 family can be activated by interferon signaling, which suggests a role in the immune system and in host-pathogen interactions, especially in response to viral infections. In this review, we summarize current knowledge on the genomic organization and regulation of the miR-29 family and we provide an overview of its implication in cancer suppression and promotion as well as in host immune responses. The numerous remarkable properties of these miRNAs and their often altered expression patterns might make the miR-29 family promising biomarkers and therapeutic targets for various diseases in future. © 2013 Bentham Science Publishers.
http://hdl.handle.net/10993/20275
10.2174/1566524011313040009
http://www.scopus.com/inward/record.url?eid=2-s2.0-84876717265&partnerID=40&md5=c8b87fa2bc6671a7e0490d5b707faf4d
cited By (since 1996)0
Scopus

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Limited access
Schmitt et al_review_2012.pdfPublisher postprint2.09 MBRequest a copy

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.